Edition:
United States

Fresenius Medical Care AG & Co KGaA (FMEG.DE)

FMEG.DE on Xetra

70.16EUR
18 Apr 2019
Change (% chg)

€-1.22 (-1.71%)
Prev Close
€71.38
Open
€71.00
Day's High
€71.04
Day's Low
€69.84
Volume
1,727,065
Avg. Vol
981,807
52-wk High
€91.74
52-wk Low
€55.44

Latest Key Developments (Source: Significant Developments)

Fmc AG Will Implement A Share Buy-Back Programme
Monday, 11 Mar 2019 01:27pm EDT 

March 11 (Reuters) - Fresenius Medical Care AG & Co KGaA ::WILL IMPLEMENT A SHARE BUY-BACK PROGRAMME.TO BUY BACK UP TO A MAXIMUM OF 6 MILLION ORDINARY SHARES.WILL BE REPURCHASED AT A TOTAL PURCHASE PRICE (EXCLUDING ANCILLARY TRANSACTION COSTS) OF UP TO 330 MILLION EURO.SAYS BUYBACK CORRESPONDS TO APPROXIMATELY 1.6 PERCENT OF SHARE CAPITAL OF FRESENIUS MEDICAL CARE.  Full Article

Fresenius Medical Care Completes Acquisition Of NxStage Medical, Announces Acquisition Effects
Tuesday, 26 Feb 2019 06:59am EST 

Feb 26 (Reuters) - FMC AG ::DGAP-NEWS: FRESENIUS MEDICAL CARE COMPLETES ACQUISITION OF NXSTAGE MEDICAL.COMPANY NOW EXPECTS LOWER TOTAL INTEGRATION COSTS OF AROUND EUR 50 TO EUR 75 MILLION OVER THREE YEARS FOLLOWING CLOSING OF TRANSACTION.OPERATING INCOME IS EXPECTED TO IMPROVE FROM 2020 ONWARDS DUE TO REALIZATION OF ANTICIPATED SYNERGIES FROM ACQUISITION.ESTIMATED EFFECTS OF NXSTAGE ACQUISITION (EXCLUDING INTEGRATION COSTS): IN 2019, REVENUES OF 240 MILLION TO 260 MILLION EUR.ESTIMATED EFFECTS OF NXSTAGE ACQUISITION (EXCLUDING INTEGRATION COSTS): IN 2020, REVENUES OF 310 MILLION EUR TO 330 MILLION EUR.ESTIMATED EFFECTS OF NXSTAGE ACQUISITION (EXCLUDING INTEGRATION COSTS): IN 2020, EBIT OF 20 MILLION EUR TO 30 MILLION EUR.2019 EFFECTS: OPERATING INCOME (EBIT) -30 MILLION EUR TO -20 MILLION EUR, 2020 EFFECT: 20 MILLION EUR TO 30 MILLION EUR.ESTIMATED EFFECTS: IN 2020, NET LOSS OF 40 MILLION EUR TO 30 MILLION EUR, WHILE IN 2019 NET LOSS OF 75 MILLION EUR TO 65 MILLION EUR.  Full Article

FMC Sees NxStage Revenue Contribution At 310-330 Mln Eur In 2020
Tuesday, 26 Feb 2019 06:59am EST 

Feb 26 (Reuters) - Fresenius Medical Care AG & Co KGaA ::ESTIMATED EFFECTS OF NXSTAGE ACQUISITION (EXCLUDING INTEGRATION COSTS): IN 2019, REVENUES OF 240 MILLION TO 260 MILLION EUR.ESTIMATED EFFECTS OF NXSTAGE ACQUISITION (EXCLUDING INTEGRATION COSTS): IN 2020, 310 MILLION EUR TO 330 MILLION EUR.  Full Article

Fresenius Medical Care Q4 Net Income +8 pct to 425 Mln EUR
Wednesday, 20 Feb 2019 12:59am EST 

Feb 20 (Reuters) - Fresenius Medical Care AG & Co KGaA ::Q4 SALES DOWN 3 PERCENT TO 4.3 BILLION EUR (VERSUS 4.225 BILLION EUR IN REUTERS F'CAST).Q4 NET INCOME UP 8 PERCENT TO 425 MILLION EUR.Q4 EBIT UP 18 PERCENT TO 613 MILLION EUR.PROPOSES DIVIDEND OF 1.17 EUR PER SHARE.PROJECTS ADJUSTED SALES GROWTH OF 3-7 PERCENT FOR 2019.EXPECTS ADJUSTED NET INCOME OF -2 PERCENT TO +2 PERCENT IN 2019.SEES STRONGLY ACCELERATED PROFIT GROWTH IN 2020.SAYS EXPECTS NXSTAGE DEAL TO CLOSE IN Q1 OF 2019.  Full Article

Fresenius Medical Care And NxStage Extend Merger End-Date Due To Government Shutdown
Tuesday, 29 Jan 2019 08:04am EST 

Jan 29 (Reuters) - FMC AG ::MERGER AGREEMENT’S END-DATE HAS BEEN EXTENDED TO AUGUST 6, 2019, OR SUCH EARLIER DATE ON WHICH THERE HAS BEEN 60 CONSECUTIVE DAYS OF FULL FUNDING OF THE FTC’S OPERATIONS.FRESENIUS MEDICAL CARE AND NXSTAGE EXTEND MERGER END-DATE DUE TO GOVERNMENT SHUTDOWN.  Full Article

Fresenius Medical Care AG & Co. KGaA Gives Early Preliminary Indicative Guidance For 2019
Thursday, 6 Dec 2018 04:35pm EST 

Dec 6 (Reuters) - Fresenius Medical Care AG & Co KGaA ::DGAP-ADHOC: FRESENIUS MEDICAL CARE AG & CO. KGAA GIVES EARLY PRELIMINARY INDICATIVE GUIDANCE FOR 2019.FOR 2019, CO CURRENTLY BROADLY ASSUMES SOLID COMPARABLE REVENUE GROWTH AND COMPARABLE NET INCOME TO BE AROUND LEVEL OF FY 2018.FRESENIUS MEDICAL CARE IS CURRENTLY REVIEWING ALL FACTORS AS PART OF ITS BUDGETING PROCESS.  Full Article

Fresenius Medical Care CEO Says Actively Evaluating M&A Opportunities
Tuesday, 30 Oct 2018 11:50am EDT 

Oct 30 (Reuters) - Fresenius Medical Care AG & Co KGaA ::FRESENIUS MEDICAL CARE CFO SAYS WE CONTINUE TO ACTIVELY EVALUATE M&A OPPORTUNITIES.FRESENIUS MEDICAL CARE CEO SAYS DOES NOT EXPECT TO NEED TO DO FURTHER DISPOSALS TO CLOSE NXSTAGE DEAL.  Full Article

Fresenius Medical Care Says Gregor Zuend Appointed For Supervisory Board
Monday, 29 Oct 2018 02:21pm EDT 

Oct 29 (Reuters) - Fresenius Medical Care AG & Co KGaA ::SAYS GREGOR ZUEND APPOINTED FOR SUPERVISORY BOARD OF FRESENIUS MEDICAL CARE.  Full Article

FMC Affirms FY Guidance After Q2 Results
Tuesday, 31 Jul 2018 01:00am EDT 

July 31 (Reuters) - Fresenius Medical Care AG & Co KGaA ::SAYS Q2 SALES 4.214 BILLION EUROS.Q2 EBIT 568 MILLION EUROS.Q2 ADJUSTED. NET INCOME 308 MILLION.CONFIRMS FULL-YEAR GUIDANCE.  Full Article

Fresenius Announces Immediate Availability In U.S. Of Adenosine Injections
Tuesday, 10 Jul 2018 05:00pm EDT 

July 10 (Reuters) - Fresenius Medical Care AG & Co KGaA ::FRESENIUS KABI SAYS ANNOUNCED IMMEDIATE AVAILABILITY IN U.S. OF ADENOSINE INJECTION, USP IN 60 MG PER 20 ML AND 90 MG PER 30 ML PRESENTATIONS.  Full Article

Photo

Fresenius Medical Care to pay $231 million to resolve criminal, civil foreign bribery charges

Germany-based dialysis clinic operator Fresenius Medical Care AG will pay about $231 million to resolve criminal and civil allegations that the company paid bribes to public health and government officials in several countries to win or retain business, the U.S. Justice Department said on Friday.